Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00791843Phase 2Completed
A Phase 2 trial of growth hormone releasing hormone 1-44 in heart failure (HF), sponsored by University of Pennsylvania. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00791843.